Conexeu Sciences Inc.

NasdaqCM:CNXU Stock Report

Market Cap: US$253.9m

Conexeu Sciences Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Mike Harrison

Chief executive officer

US$199.4k

Total compensation

CEO salary percentage7.52%
CEO tenureless than a year
CEO ownershipn/a
Management average tenure1.3yrs
Board average tenureless than a year

Recent management updates

Recent updates

Analysis Article • Jun 21

Conexeu Sciences (CNXU) Stock Could Be 47.6% Undervalued After FDA Prep And Leadership Moves

Conexeu Sciences (CNXU) has drawn fresh attention after expanding its board and executive team, including naming co founder David Bogart as Chief Commercial Officer, as it moves its CXU wound care platform toward FDA 510(k) preparation. See our latest analysis for Conexeu Sciences. Recent appointments around the CXU platform come after a period of mixed trading, with a 7 day share price return of 17.63% and a 30 day share price return that declined 7.78% from a latest close of $13.28. This...

CEO Compensation Analysis

How has Mike Harrison's remuneration changed compared to Conexeu Sciences's earnings?
DateTotal CompensationSalaryCompany Earnings
Apr 30 2026n/an/a

-US$7m

Jan 31 2026n/an/a

-US$5m

Oct 31 2025US$199kUS$15k

-US$4m

Compensation vs Market: Mike's total compensation ($USD199.45K) is below average for companies of similar size in the US market ($USD1.61M).

Compensation vs Earnings: Insufficient data to compare Mike's compensation with company performance.

CEO

Mike Harrison (61 yo)

less than a year
Tenure
US$199,445
Compensation

Mr. Miles D. Harrison, also known as Mike, is President & CEO and Director of Conexeu Sciences Inc. Mr. Harrison has been an Independent Director of Castle Biosciences, Inc. since April 2, 2020. Mr. Harris...

Leadership Team

NamePositionTenureCompensationOwnership
Miles Harrison
Presidentless than a yearUS$199.45kno data
David Bogart
Founderno dataUS$265.54kno data
Claudia Chavez-Munoz
Founder & Chief Scientific Officer1.3yrsUS$283.04kno data
Stephen Inouye
CFO, Corporate Secretary & Treasurer2.7yrsUS$161.90kno data
Brian Pilcher
Chief Medical Officer1.3yrsUS$360.77kno data
Sonia Thomas
Head of Strategy & Transformationless than a yearno datano data
JR Falconne
Head of Business Development & Licensingno datano datano data
1.3yrs
Average Tenure
57yo
Average Age

Experienced Management: CNXU's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Miles Harrison
Presidentless than a yearUS$199.45kno data
David Bogart
Founder2.7yrsUS$265.54kno data
Jeffrey Sharpe
Chairman of the Board1.2yrsUS$831.82k3.74%
$ 9.5m
Anthony Papp
Medical Advisorno datano datano data
Scott Rineer
Medical Advisorno datano datano data
Ana Bastiani-Posner
Directorless than a yearno datano data
Aaron Farberg
Independent Directorless than a yearno datano data
Andrew Costa
Directorless than a yearno datano data
Vijay Gorantla
Medical Advisorno datano datano data
Zbigniew Lorenc
Independent Director1.2yrsUS$270.00kno data
Sebastian Purcell
Independent Directorless than a yearno datano data
Peter Randelzhofer
Medical Advisorno datano datano data
0.8yrs
Average Tenure
54yo
Average Age

Experienced Board: CNXU's board of directors are not considered experienced ( 0.8 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/08 13:47
End of Day Share Price 2026/07/08 00:00
Earnings2026/04/30
Annual Earnings2025/10/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Conexeu Sciences Inc. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Swayampakula RamakanthH.C. Wainwright & Co.